McKesson Extends CVS Health Pact To 2032
McKesson Corp. (MCK) has signed an agreement in principle to extend its partnership with CVS Health Corp. (CVS) to supply medicines through 2032. The company also reaffirmed its FY27 Adjusted EPS guidance.
McKesson Corp. (MCK) has signed an agreement in principle to extend its partnership with CVS Health Corp. (CVS) to supply medicines through 2032. The company also reaffirmed its FY27 Adjusted EPS guidance.